Product
Albendazole + Ivermectin
1 clinical trial
2 indications
Indication
HelminthiasisIndication
IntestinalClinical trial
An Adaptive Phase II/III SingleBlinded, Randomized, MultiCentre, ParallelGroup, Active Controlled, Superiority Study to Evaluate the Safety and Efficacy of a Single Day or 3day Single Dose of an ALBENDAZOLE IVERMECTIN Coformulation vs ALBENDAZOLE for the Treatment of SoilTransmitted Helminth Infections (Trichuris Trichiura, Hookworm, Strongyloides Stercoralis) in Paediatric and Young Adult PopulationStatus: Terminated, Estimated PCD: 2023-03-21